CLSD Projected Dividend Yield
Clearside Biomedical Inc ( NASDAQ : CLSD )Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). Co.'s SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Co. is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. 21 YEAR PERFORMANCE RESULTS |
CLSD Dividend History Detail CLSD Dividend News CLSD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |